cancer therapeutics. As the national discussion around health care costs and value continues, a practical working description of value in oncology would benefit many stakeholders and serve as a useful model for other fields of medicine.
The first part of the workshop focused on features of oncology that impact the value proposition. The second part presented potential approaches to improve value in cancer care. During the final session, participants discussed how the concept of value in cancer care is understood now and how it may be understood in the future, exploring any contrasting views and building on areas of agreement.
It is hoped that readers of this will gain insight into the many facets of and challenges to assessing value in cancer care, and perhaps feel the enthusiasm shared by the workshop participants regarding the need to better define value, such that cancer care can improve patients’ lives as efficiently and effectively as possible under the reality of the need to control spiraling health care costs.
Scott D. Ramsey, M.D., Ph.D.
Chair, Planning Committee on Assessing and Improving Value in Cancer Care
Member, National Cancer Policy Forum
Member, Fred Hutchinson Cancer Research Center